1. Home
  2. Labeler Index
  3. Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.
  4. 23155-749
  5. NDC Package Code: 23155-749-05 Benazepril Hydrochloride

NDC Package 23155-749-05 Benazepril Hydrochloride

Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
23155-749-05
Package Description:
500 TABLET in 1 BOTTLE
Product Code:
23155-749
Proprietary Name:
Benazepril Hydrochloride
Non-Proprietary Name:
Benazepril Hydrochloride
Substance Name:
Benazepril Hydrochloride
Usage Information:
Benazepril hydrochloride is indicated for the treatment of hypertension, to lower blood pressure.  Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.  These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs.Benazepril hydrochloride is indicated for the treatment of hypertension, to lower blood pressure.  Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.  These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs.Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mm Hg is greater at higher blood pressures, so that even modest reductions of severe hyper-tension can provide substantial benefit.  Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in Black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.It may be used alone or in combination with thiazide diuretics.
11-Digit NDC Billing Format:
23155074905
NDC to RxNorm Crosswalk:
  • RxCUI: 898687 - benazepril HCl 10 MG Oral Tablet
  • RxCUI: 898687 - benazepril hydrochloride 10 MG Oral Tablet
  • RxCUI: 898687 - BZP hydrochloride 10 MG Oral Tablet
  • RxCUI: 898690 - benazepril HCl 20 MG Oral Tablet
  • RxCUI: 898690 - benazepril hydrochloride 20 MG Oral Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.
    Dosage Form:
    Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • BENAZEPRIL HYDROCHLORIDE 5 mg/1
    • Pharmacologic Class(es):
  • Angiotensin Converting Enzyme Inhibitor - [EPC] (Established Pharmacologic Class)
  • Angiotensin-converting Enzyme Inhibitors - [MoA] (Mechanism of Action)
  • Decreased Blood Pressure - [PE] (Physiologic Effect)
    • Sample Package:
    No
    FDA Application Number:
    ANDA076267
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    08-20-2022
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    23155-749-01100 TABLET in 1 BOTTLE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 23155-749-05?

    The NDC Packaged Code 23155-749-05 is assigned to a package of 500 tablet in 1 bottle of Benazepril Hydrochloride, a human prescription drug labeled by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.. The product's dosage form is tablet and is administered via oral form.

    Is NDC 23155-749 included in the NDC Directory?

    Yes, Benazepril Hydrochloride with product code 23155-749 is active and included in the NDC Directory. The product was first marketed by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc. on August 20, 2022 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 23155-749-05?

    The 11-digit format is 23155074905. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-223155-749-055-4-223155-0749-05